Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.

Hu T, Pan C, Zhang T, Ni M, Wang W, Zhang S, Chen Y, Wang J, Fang Q

Open source

DOI
10.1038/s41417-022-00501-1
Published
2022 Nov
Container
Cancer gene therapy
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41417-022-00501-1,
  title = {Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.},
  author = {Hu T and Pan C and Zhang T and Ni M and Wang W and Zhang S and Chen Y and Wang J and Fang Q},
  year = {2022},
  journal = {Cancer gene therapy},
  doi = {10.1038/s41417-022-00501-1},
  url = {https://doi.org/10.1038/s41417-022-00501-1}
}

RIS

TY  - JOUR
TI  - Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.
AU  - Hu T
AU  - Pan C
AU  - Zhang T
AU  - Ni M
AU  - Wang W
AU  - Zhang S
AU  - Chen Y
AU  - Wang J
AU  - Fang Q
PY  - 2022
JO  - Cancer gene therapy
DO  - 10.1038/s41417-022-00501-1
UR  - https://doi.org/10.1038/s41417-022-00501-1
ER  - 

APA

T, H., C, P., T, Z., M, N., W, W., S, Z., Y, C., J, W., & Q, F. (2022). Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.. Cancer gene therapy. https://doi.org/10.1038/s41417-022-00501-1

Source records